| Symbol |
Name |
|
ABI3BP
|
ABI family, member 3 (NESH) binding protein
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ABL2
|
ABL proto-oncogene 2, non-receptor tyrosine kinase
|
|
ACER2
|
alkaline ceramidase 2
|
|
ACVRL1
|
activin A receptor type II-like 1
|
|
ADA
|
adenosine deaminase
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
|
ADAM15
|
ADAM metallopeptidase domain 15
|
|
ADAM22
|
ADAM metallopeptidase domain 22
|
|
ADAM8
|
ADAM metallopeptidase domain 8
|
|
ADAM9
|
ADAM metallopeptidase domain 9
|
|
ADAMDEC1
|
ADAM-like, decysin 1
|
|
ADAMTS18
|
ADAM metallopeptidase with thrombospondin type 1 motif, 18
|
|
ADGRG1
|
adhesion G protein-coupled receptor G1
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADK
|
adenosine kinase
|
|
AIF1
|
allograft inflammatory factor 1
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALOX12
|
arachidonate 12-lipoxygenase
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANK3
|
ankyrin 3, node of Ranvier (ankyrin G)
|
|
AP1AR
|
adaptor-related protein complex 1 associated regulatory protein
|
|
AP3B1
|
adaptor-related protein complex 3, beta 1 subunit
|
|
AP3D1
|
adaptor-related protein complex 3, delta 1 subunit
|
|
APC
|
adenomatous polyposis coli
|
|
APOA1
|
apolipoprotein A-I
|
|
APOD
|
apolipoprotein D
|
|
ARHGAP6
|
Rho GTPase activating protein 6
|
|
ARHGDIA
|
Rho GDP dissociation inhibitor (GDI) alpha
|
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta
|
|
ARHGDIG
|
Rho GDP dissociation inhibitor (GDI) gamma
|
|
ARHGEF7
|
Rho guanine nucleotide exchange factor (GEF) 7
|
|
ARL2
|
ADP-ribosylation factor-like 2
|
|
ARPC2
|
actin related protein 2/3 complex, subunit 2, 34kDa
|
|
ASS1
|
argininosuccinate synthase 1
|
|
ATP5B
|
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide
|
|
ATXN3
|
ataxin 3
|
|
AZU1
|
azurocidin 1
|
|
B4GALNT2
|
beta-1,4-N-acetyl-galactosaminyl transferase 2
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BAG4
|
BCL2-associated athanogene 4
|
|
BCAS3
|
breast carcinoma amplified sequence 3
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BLM
|
Bloom syndrome, RecQ helicase-like
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BTLA
|
B and T lymphocyte associated
|
|
BTN2A2
|
butyrophilin, subfamily 2, member A2
|
|
C10ORF54
|
chromosome 10 open reading frame 54
|
|
C1QBP
|
complement component 1, q subcomponent binding protein
|
|
C1QTNF1
|
C1q and tumor necrosis factor related protein 1
|
|
CALR
|
calreticulin
|
|
CAMK4
|
calcium/calmodulin-dependent protein kinase IV
|
|
CARD11
|
caspase recruitment domain family, member 11
|
|
CASK
|
calcium/calmodulin-dependent serine protein kinase (MAGUK family)
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBLB
|
Cbl proto-oncogene B, E3 ubiquitin protein ligase
|
|
CBLL1
|
Cbl proto-oncogene-like 1, E3 ubiquitin protein ligase
|
|
CCDC80
|
coiled-coil domain containing 80
|
|
CCL19
|
chemokine (C-C motif) ligand 19
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL21
|
chemokine (C-C motif) ligand 21
|
|
CCL25
|
chemokine (C-C motif) ligand 25
|
|
CCL28
|
chemokine (C-C motif) ligand 28
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCM2L
|
cerebral cavernous malformation 2-like
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD164
|
CD164 molecule, sialomucin
|
|
CD1D
|
CD1d molecule
|
|
CD2
|
CD2 molecule
|
|
CD209
|
CD209 molecule
|
|
CD24
|
CD24 molecule
|
|
CD247
|
CD247 molecule
|
|
CD274
|
CD274 molecule
|
|
CD276
|
CD276 molecule
|
|
CD28
|
CD28 molecule
|
|
CD300A
|
CD300a molecule
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CD3D
|
CD3d molecule, delta (CD3-TCR complex)
|
|
CD3E
|
CD3e molecule, epsilon (CD3-TCR complex)
|
|
CD3G
|
CD3g molecule, gamma (CD3-TCR complex)
|
|
CD4
|
CD4 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
|
CD47
|
CD47 molecule
|
|
CD5
|
CD5 molecule
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
|
CD80
|
CD80 molecule
|
|
CD83
|
CD83 molecule
|
|
CD86
|
CD86 molecule
|
|
CDC42
|
cell division cycle 42
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH13
|
cadherin 13
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CELSR2
|
cadherin, EGF LAG seven-pass G-type receptor 2
|
|
CHRD
|
chordin
|
|
CIB1
|
calcium and integrin binding 1 (calmyrin)
|
|
CITED2
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
|
|
CLC
|
Charcot-Leyden crystal galectin
|
|
CLPTM1
|
cleft lip and palate associated transmembrane protein 1
|
|
COL16A1
|
collagen, type XVI, alpha 1
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL26A1
|
collagen, type XXVI, alpha 1
|
|
COL8A1
|
collagen, type VIII, alpha 1
|
|
CORO1A
|
coronin, actin binding protein, 1A
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
|
CSK
|
c-src tyrosine kinase
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
CYTH1
|
cytohesin 1
|
|
CYTH2
|
cytohesin 2
|
|
CYTH3
|
cytohesin 3
|
|
CYTH4
|
cytohesin 4
|
|
CYTIP
|
cytohesin 1 interacting protein
|
|
DAB1
|
Dab, reelin signal transducer, homolog 1 (Drosophila)
|
|
DAB2
|
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila)
|
|
DACT2
|
dishevelled-binding antagonist of beta-catenin 2
|
|
DAPK3
|
death-associated protein kinase 3
|
|
DDR1
|
discoidin domain receptor tyrosine kinase 1
|
|
DENND6A
|
DENN/MADD domain containing 6A
|
|
DHPS
|
deoxyhypusine synthase
|
|
DLC1
|
DLC1 Rho GTPase activating protein
|
|
DLG1
|
discs, large homolog 1 (Drosophila)
|
|
DLL1
|
delta-like 1 (Drosophila)
|
|
DMP1
|
dentin matrix acidic phosphoprotein 1
|
|
DMTN
|
dematin actin binding protein
|
|
DNAJA3
|
DnaJ (Hsp40) homolog, subfamily A, member 3
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DSCAM
|
Down syndrome cell adhesion molecule
|
|
DSCAML1
|
Down syndrome cell adhesion molecule like 1
|
|
DTX1
|
deltex 1, E3 ubiquitin ligase
|
|
DUSP26
|
dual specificity phosphatase 26 (putative)
|
|
DUSP3
|
dual specificity phosphatase 3
|
|
EBI3
|
Epstein-Barr virus induced 3
|
|
ECM2
|
extracellular matrix protein 2, female organ and adipocyte specific
|
|
EDIL3
|
EGF-like repeats and discoidin I-like domains 3
|
|
EFNA1
|
ephrin-A1
|
|
EFNA5
|
ephrin-A5
|
|
EFNB1
|
ephrin-B1
|
|
EGFL6
|
EGF-like-domain, multiple 6
|
|
EGFLAM
|
EGF-like, fibronectin type III and laminin G domains
|
|
EGR3
|
early growth response 3
|
|
EMILIN1
|
elastin microfibril interfacer 1
|
|
EMP2
|
epithelial membrane protein 2
|
|
EPB41L5
|
erythrocyte membrane protein band 4.1 like 5
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHA1
|
EPH receptor A1
|
|
EPHA2
|
EPH receptor A2
|
|
EPHA3
|
EPH receptor A3
|
|
EPHA7
|
EPH receptor A7
|
|
EPHA8
|
EPH receptor A8
|
|
EPHB3
|
EPH receptor B3
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FAF1
|
Fas (TNFRSF6) associated factor 1
|
|
FAM21C
|
family with sequence similarity 21, member C
|
|
FBLN2
|
fibulin 2
|
|
FERMT3
|
fermitin family member 3
|
|
FES
|
FES proto-oncogene, tyrosine kinase
|
|
FGA
|
fibrinogen alpha chain
|
|
FGB
|
fibrinogen beta chain
|
|
FGG
|
fibrinogen gamma chain
|
|
FLCN
|
folliculin
|
|
FLNA
|
filamin A, alpha
|
|
FOXA1
|
forkhead box A1
|
|
FOXA2
|
forkhead box A2
|
|
FOXC2
|
forkhead box C2
|
|
FOXF1
|
forkhead box F1
|
|
FOXJ1
|
forkhead box J1
|
|
FOXN1
|
forkhead box N1
|
|
FOXP3
|
forkhead box P3
|
|
FSTL3
|
follistatin-like 3 (secreted glycoprotein)
|
|
FXYD5
|
FXYD domain containing ion transport regulator 5
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
FZD4
|
frizzled class receptor 4
|
|
FZD7
|
frizzled class receptor 7
|
|
GATA3
|
GATA binding protein 3
|
|
GCNT2
|
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group)
|
|
GLI2
|
GLI family zinc finger 2
|
|
GLI3
|
GLI family zinc finger 3
|
|
GLMN
|
glomulin, FKBP associated protein
|
|
GPAM
|
glycerol-3-phosphate acyltransferase, mitochondrial
|
|
GPM6B
|
glycoprotein M6B
|
|
GRAP2
|
GRB2-related adaptor protein 2
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
GREM1
|
gremlin 1, DAN family BMP antagonist
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GTPBP4
|
GTP binding protein 4
|
|
HAS2
|
hyaluronan synthase 2
|
|
HES1
|
hes family bHLH transcription factor 1
|
|
HHLA2
|
HERV-H LTR-associating 2
|
|
HLA-DMB
|
major histocompatibility complex, class II, DM beta
|
|
HLA-DOA
|
major histocompatibility complex, class II, DO alpha
|
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-DQA2
|
major histocompatibility complex, class II, DQ alpha 2
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DQB2
|
major histocompatibility complex, class II, DQ beta 2
|
|
HLA-DRA
|
major histocompatibility complex, class II, DR alpha
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-DRB3
|
major histocompatibility complex, class II, DR beta 3
|
|
HLA-DRB4
|
major histocompatibility complex, class II, DR beta 4
|
|
HLA-DRB5
|
major histocompatibility complex, class II, DR beta 5
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HLX
|
H2.0-like homeobox
|
|
HOXA7
|
homeobox A7
|
|
HRG
|
histidine-rich glycoprotein
|
|
HSD17B12
|
hydroxysteroid (17-beta) dehydrogenase 12
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
HSPH1
|
heat shock 105kDa/110kDa protein 1
|
|
HYAL1
|
hyaluronoglucosaminidase 1
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICOS
|
inducible T-cell co-stimulator
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFNA2
|
interferon, alpha 2
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IFNL1
|
interferon, lambda 1
|
|
IFT74
|
intraflagellar transport 74
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IHH
|
indian hedgehog
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IL10
|
interleukin 10
|
|
IL12A
|
interleukin 12A
|
|
IL12B
|
interleukin 12B
|
|
IL12RB1
|
interleukin 12 receptor, beta 1
|
|
IL15
|
interleukin 15
|
|
IL18
|
interleukin 18
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL20RB
|
interleukin 20 receptor beta
|
|
IL21
|
interleukin 21
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL23R
|
interleukin 23 receptor
|
|
IL27
|
interleukin 27
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL36B
|
interleukin 36, beta
|
|
IL36R
|
interleukin 36 receptor
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL6
|
interleukin 6
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
IL7
|
interleukin 7
|
|
IL7R
|
interleukin 7 receptor
|
|
ILK
|
integrin-linked kinase
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRF4
|
interferon regulatory factor 4
|
|
ITCH
|
itchy E3 ubiquitin protein ligase
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA3
|
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGA6
|
integrin, alpha 6
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB1BP1
|
integrin beta 1 binding protein 1
|
|
ITPKB
|
inositol-trisphosphate 3-kinase B
|
|
JAG2
|
jagged 2
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
JAM2
|
junctional adhesion molecule 2
|
|
KANK1
|
KN motif and ankyrin repeat domains 1
|
|
KDR
|
kinase insert domain receptor
|
|
KIF14
|
kinesin family member 14
|
|
KIF26B
|
kinesin family member 26B
|
|
KIFAP3
|
kinesin-associated protein 3
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KNG1
|
kininogen 1
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
LAG3
|
lymphocyte-activation gene 3
|
|
LAMA1
|
laminin, alpha 1
|
|
LAMA2
|
laminin, alpha 2
|
|
LAMA3
|
laminin, alpha 3
|
|
LAMA4
|
laminin, alpha 4
|
|
LAMA5
|
laminin, alpha 5
|
|
LAMB1
|
laminin, beta 1
|
|
LAT
|
linker for activation of T cells
|
|
LAX1
|
lymphocyte transmembrane adaptor 1
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LDB1
|
LIM domain binding 1
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LGALS8
|
lectin, galactoside-binding, soluble, 8
|
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
|
|
LIMS1
|
LIM and senescent cell antigen-like domains 1
|
|
LMO7
|
LIM domain 7
|
|
LPXN
|
leupaxin
|
|
LRRC16A
|
leucine rich repeat containing 16A
|
|
LRRC32
|
leucine rich repeat containing 32
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MACF1
|
microtubule-actin crosslinking factor 1
|
|
MAD2L2
|
MAD2 mitotic arrest deficient-like 2 (yeast)
|
|
MALT1
|
MALT1 paracaspase
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K5
|
mitogen-activated protein kinase kinase 5
|
|
MAP3K14
|
mitogen-activated protein kinase kinase kinase 14
|
|
MAP3K7
|
mitogen-activated protein kinase kinase kinase 7
|
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MAPKAP1
|
mitogen-activated protein kinase associated protein 1
|
|
MFI2
|
antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5
|
|
MIA3
|
melanoma inhibitory activity family, member 3
|
|
MINK1
|
misshapen-like kinase 1
|
|
MLST8
|
MTOR associated protein, LST8 homolog (S. cerevisiae)
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC22
|
mucin 22
|
|
MYADM
|
myeloid-associated differentiation marker
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYF5
|
myogenic factor 5
|
|
MYO10
|
myosin X
|
|
MYO1F
|
myosin IF
|
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response
|
|
NCK1
|
NCK adaptor protein 1
|
|
NCK2
|
NCK adaptor protein 2
|
|
NCKAP1L
|
NCK-associated protein 1-like
|
|
NDFIP1
|
Nedd4 family interacting protein 1
|
|
NDNF
|
neuron-derived neurotrophic factor
|
|
NET1
|
neuroepithelial cell transforming 1
|
|
NF1
|
neurofibromin 1
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFKBID
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, delta
|
|
NID1
|
nidogen 1
|
|
NINJ1
|
ninjurin 1
|
|
NKAP
|
NFKB activating protein
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NODAL
|
nodal growth differentiation factor
|
|
NOTCH1
|
notch 1
|
|
NPNT
|
nephronectin
|
|
NPY2R
|
neuropeptide Y receptor Y2
|
|
NRARP
|
NOTCH-regulated ankyrin repeat protein
|
|
NUAK1
|
NUAK family, SNF1-like kinase, 1
|
|
OLFM4
|
olfactomedin 4
|
|
ONECUT1
|
one cut homeobox 1
|
|
ONECUT2
|
one cut homeobox 2
|
|
PAG1
|
phosphoprotein membrane anchor with glycosphingolipid microdomains 1
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PAK2
|
p21 protein (Cdc42/Rac)-activated kinase 2
|
|
PAK3
|
p21 protein (Cdc42/Rac)-activated kinase 3
|
|
PAWR
|
PRKC, apoptosis, WT1, regulator
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD1LG2
|
programmed cell death 1 ligand 2
|
|
PDE3B
|
phosphodiesterase 3B, cGMP-inhibited
|
|
PDE5A
|
phosphodiesterase 5A, cGMP-specific
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase 1
|
|
PELI1
|
pellino E3 ubiquitin protein ligase 1
|
|
PIEZO1
|
piezo-type mechanosensitive ion channel component 1
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PKP4
|
plakophilin 4
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLEKHA2
|
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 2
|
|
PLET1
|
placenta expressed transcript 1
|
|
PLG
|
plasminogen
|
|
PLXNB1
|
plexin B1
|
|
PLXNB3
|
plexin B3
|
|
PNP
|
purine nucleoside phosphorylase
|
|
PODXL
|
podocalyxin-like
|
|
PPM1F
|
protein phosphatase, Mg2+/Mn2+ dependent, 1F
|
|
PPP1CB
|
protein phosphatase 1, catalytic subunit, beta isozyme
|
|
PPP1R12A
|
protein phosphatase 1, regulatory subunit 12A
|
|
PPP2CA
|
protein phosphatase 2, catalytic subunit, alpha isozyme
|
|
PPP2R1A
|
protein phosphatase 2, regulatory subunit A, alpha
|
|
PRELID1
|
PRELI domain containing 1
|
|
PREX1
|
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRKCQ
|
protein kinase C, theta
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRKD2
|
protein kinase D2
|
|
PRKG1
|
protein kinase, cGMP-dependent, type I
|
|
PRKX
|
protein kinase, X-linked
|
|
PRLR
|
prolactin receptor
|
|
PRNP
|
prion protein
|
|
PRSS2
|
protease, serine, 2 (trypsin 2)
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN2
|
protein tyrosine phosphatase, non-receptor type 2
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTPN23
|
protein tyrosine phosphatase, non-receptor type 23
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
PTPRG
|
protein tyrosine phosphatase, receptor type, G
|
|
PTPRJ
|
protein tyrosine phosphatase, receptor type, J
|
|
PTPRO
|
protein tyrosine phosphatase, receptor type, O
|
|
PTPRR
|
protein tyrosine phosphatase, receptor type, R
|
|
PYCARD
|
PYD and CARD domain containing
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)
|
|
RAC3
|
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)
|
|
RAG1
|
recombination activating gene 1
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RASA1
|
RAS p21 protein activator (GTPase activating protein) 1
|
|
RC3H1
|
ring finger and CCCH-type domains 1
|
|
RCC2
|
regulator of chromosome condensation 2
|
|
RELL2
|
RELT-like 2
|
|
RET
|
ret proto-oncogene
|
|
RGCC
|
regulator of cell cycle
|
|
RHOD
|
ras homolog family member D
|
|
RICTOR
|
RPTOR independent companion of MTOR, complex 2
|
|
RIPK2
|
receptor-interacting serine-threonine kinase 2
|
|
RIPK3
|
receptor-interacting serine-threonine kinase 3
|
|
RLTPR
|
RGD motif, leucine rich repeats, tropomodulin domain and proline-rich containing
|
|
RNASE10
|
ribonuclease, RNase A family, 10 (non-active)
|
|
RND1
|
Rho family GTPase 1
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
ROCK2
|
Rho-associated, coiled-coil containing protein kinase 2
|
|
RORC
|
RAR-related orphan receptor C
|
|
RREB1
|
ras responsive element binding protein 1
|
|
RSU1
|
Ras suppressor protein 1
|
|
S100A10
|
S100 calcium binding protein A10
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
|
SAA1
|
serum amyloid A1
|
|
SART1
|
squamous cell carcinoma antigen recognized by T cells
|
|
SASH3
|
SAM and SH3 domain containing 3
|
|
SCGB1A1
|
secretoglobin, family 1A, member 1 (uteroglobin)
|
|
SDC4
|
syndecan 4
|
|
SEMA3E
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E
|
|
SEMA4D
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D
|
|
SEMA5A
|
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINE2
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2
|
|
SERPINF2
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2
|
|
SERPINI1
|
serpin peptidase inhibitor, clade I (neuroserpin), member 1
|
|
SERPINI2
|
serpin peptidase inhibitor, clade I (pancpin), member 2
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SFRP2
|
secreted frizzled-related protein 2
|
|
SFTPD
|
surfactant protein D
|
|
SHH
|
sonic hedgehog
|
|
SIPA1
|
signal-induced proliferation-associated 1
|
|
SIRPG
|
signal-regulatory protein gamma
|
|
SIT1
|
signaling threshold regulating transmembrane adaptor 1
|
|
SLC46A2
|
solute carrier family 46, member 2
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD7
|
SMAD family member 7
|
|
SMOC1
|
SPARC related modular calcium binding 1
|
|
SMOC2
|
SPARC related modular calcium binding 2
|
|
SNAI2
|
snail family zinc finger 2
|
|
SOCS5
|
suppressor of cytokine signaling 5
|
|
SOCS6
|
suppressor of cytokine signaling 6
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOX13
|
SRY (sex determining region Y)-box 13
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SPINK5
|
serine peptidase inhibitor, Kazal type 5
|
|
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2
|
|
SPOCK1
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1
|
|
SPOCK2
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPTA1
|
spectrin, alpha, erythrocytic 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRF
|
serum response factor (c-fos serum response element-binding transcription factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STX3
|
syntaxin 3
|
|
STX4
|
syntaxin 4
|
|
SYK
|
spleen tyrosine kinase
|
|
TACSTD2
|
tumor-associated calcium signal transducer 2
|
|
TBCD
|
tubulin folding cofactor D
|
|
TBX18
|
T-box 18
|
|
TDGF1
|
teratocarcinoma-derived growth factor 1
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TESC
|
tescalcin
|
|
TESPA1
|
thymocyte expressed, positive selection associated 1
|
|
TFE3
|
transcription factor binding to IGHM enhancer 3
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGM2
|
transglutaminase 2
|
|
THBS1
|
thrombospondin 1
|
|
THY1
|
Thy-1 cell surface antigen
|
|
TIGIT
|
T cell immunoreceptor with Ig and ITIM domains
|
|
TIPE2
|
TNF alpha induced protein 8 like 2
|
|
TMEM102
|
transmembrane protein 102
|
|
TMIGD2
|
transmembrane and immunoglobulin domain containing 2
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF13C
|
tumor necrosis factor receptor superfamily, member 13C
|
|
TNFRSF14
|
tumor necrosis factor receptor superfamily, member 14
|
|
TNFRSF21
|
tumor necrosis factor receptor superfamily, member 21
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TNFSF14
|
tumor necrosis factor (ligand) superfamily, member 14
|
|
TNFSF18
|
tumor necrosis factor (ligand) superfamily, member 18
|
|
TNFSF4
|
tumor necrosis factor (ligand) superfamily, member 4
|
|
TNFSF9
|
tumor necrosis factor (ligand) superfamily, member 9
|
|
TNR
|
tenascin R
|
|
TPM1
|
tropomyosin 1 (alpha)
|
|
TRAF2
|
TNF receptor-associated factor 2
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
|
TRIOBP
|
TRIO and F-actin binding protein
|
|
TSC1
|
tuberous sclerosis 1
|
|
UBASH3B
|
ubiquitin associated and SH3 domain containing B
|
|
UTRN
|
utrophin
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
|
VAV3
|
vav 3 guanine nucleotide exchange factor
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VIT
|
vitrin
|
|
VNN1
|
vanin 1
|
|
VSIG4
|
V-set and immunoglobulin domain containing 4
|
|
VTCN1
|
V-set domain containing T cell activation inhibitor 1
|
|
VTN
|
vitronectin
|
|
VWC2
|
von Willebrand factor C domain containing 2
|
|
WDPCP
|
WD repeat containing planar cell polarity effector
|
|
WNT1
|
wingless-type MMTV integration site family, member 1
|
|
WNT3A
|
wingless-type MMTV integration site family, member 3A
|
|
WNT4
|
wingless-type MMTV integration site family, member 4
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
XBP1
|
X-box binding protein 1
|
|
XCL1
|
chemokine (C motif) ligand 1
|
|
YES1
|
YES proto-oncogene 1, Src family tyrosine kinase
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
|
ZBTB1
|
zinc finger and BTB domain containing 1
|
|
ZBTB16
|
zinc finger and BTB domain containing 16
|
|
ZC3H8
|
zinc finger CCCH-type containing 8
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
|
ZNF703
|
zinc finger protein 703
|
|
ZNHIT1
|
zinc finger, HIT-type containing 1
|
|
ZP3
|
zona pellucida glycoprotein 3 (sperm receptor)
|
|
ZP4
|
zona pellucida glycoprotein 4
|